| Primary information |
|---|
| ID | antitb_1306 |
| Peptide Name | D-(V13K) D1 |
| Sequence | KWKSFLKTFKSAKKTVLHTALKAISS |
| N-terminal Modification | Acetylation |
| C-terminal Modification | Amidation |
| Chemical Modification | None |
| Linear/ Cyclic | Linear |
| Length | 26 |
| Chirality | L |
| Nature | Cationic |
| Source | Synthetic |
| Origin | NA |
| Species | Mycobacterium tuberculosis |
| Strain | Mycobacterium tuberculosis H37Rv |
| Inhibition Concentartion | MIC = 70.7 μg/mL |
| In vitro/In vivo | In vitro |
| Cell Line | Human erythrocyte |
| Inhibition Concentartion | NA |
| Cytotoxicity | HC50 = 421.5 μg/mL |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Response | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other Activities | NA |
| Pubmed ID | 20858205 |
| Year of Publication | 2011 |
| 3-D Structure | NA |